Christopher Trotta

• Highlight past and ongoing efforts to develop RNA-targeted therapeutics

• Explore the history and advancement of splicing modifiers as the cornerstone in RNA-targeted discovery

• Provide a meeting roadmap, showcasing the exciting science that stems from foundational clinical successes in RNA-targeted therapeutic development